Acorda Therapeutics Operating Expenses 2011-2026 | ACOR

Annual Operating Expenses Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	206 M	279 M	279 M	348 M	439 M	355 M	275 M	239 M	223 M	191 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
439 M	191 M	283 M

Quarterly Operating Expenses Acorda Therapeutics

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	141 M	141 M	133 M	-	123 M	108 M	101 M	-	85.1 M	86.2 M	77.1 M	-	73.5 M	78.3 M	74.4 M	-	67.1 M	70.6 M	62.4 M	-	72.4 M	64.4 M	60.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
141 M	60.8 M	90 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	177 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Altimmune ALT	103 M	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.24	-3.44 %	$ 2.55 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.8	1.87 %	$ 4.36 M	China
Aprea Therapeutics APRE	16.1 M	$ 0.88	-3.72 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	-31.8 M	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aquestive Therapeutics AQST	85.5 M	$ 4.1	2.37 %	$ 356 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	248 M	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	95.9 M	$ 6.37	-2.75 %	$ 1.54 B	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
argenx SE ARGX	2.27 B	$ 756.71	-1.33 %	$ 25 B	Niderland
Armata Pharmaceuticals ARMP	45.4 M	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 25.33	-6.1 %	$ 3.22 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Artelo Biosciences ARTL	11.4 M	$ 1.15	-3.36 %	$ 2.32 M	USA
Arvinas ARVN	381 M	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	731 M	$ 61.74	-2.42 %	$ 8.26 B	USA
Ascendis Pharma A/S ASND	338 M	$ 231.56	-0.83 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.39	-1.63 %	$ 8.16 B	Australia
Actinium Pharmaceuticals ATNM	42.1 M	$ 1.17	-0.85 %	$ 35.2 M	USA
Atossa Therapeutics ATOS	31.4 M	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	361 M	$ 5.01	-7.47 %	$ 37.5 M	USA
Aurinia Pharmaceuticals AUPH	43.9 M	$ 14.14	-0.21 %	$ 1.9 B	Canada
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.68	-1.75 %	$ 429 M	Britain
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Atea Pharmaceuticals AVIR	193 M	$ 4.69	0.21 %	$ 395 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Anavex Life Sciences Corp. AVXL	51.4 M	$ 4.54	2.44 %	$ 387 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	1.18 B	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	99.1 M	$ 162.28	-0.98 %	$ 8.07 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.56	-0.58 %	$ 16.1 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA